Signaling Through NK Cell-Associated CD137 Promotes Both Helper Function for CD8+ Cytolytic T Cells and Responsiveness to IL-2 But Not Cytolytic Activity1
暂无分享,去创建一个
[1] Lieping Chen,et al. Cutting Edge: Expression of Functional CD137 Receptor by Dendritic Cells1 , 2002, The Journal of Immunology.
[2] Aaron J. Johnson,et al. Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. , 2002, The Journal of clinical investigation.
[3] A. Diefenbach,et al. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity , 2001, Nature.
[4] M. Debenedette,et al. 4-1BB Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells with Similar Efficacy1 , 2001, The Journal of Immunology.
[5] C. Takahashi,et al. Differential clonal expansion of CD4 and CD8 T cells in response to 4-1BB ligation: contribution of 4-1BB during inflammatory responses. , 2001, Immunology letters.
[6] M. Soloski. Recognition of tumor cells by the innate immune system. , 2001, Current opinion in immunology.
[7] J. Peschon,et al. Ligation of 4-1BB (CDw137) Regulates Graft-Versus-Host Disease, Graft-Versus-Leukemia, and Graft Rejection in Allogeneic Bone Marrow Transplant Recipients1 , 2001, The Journal of Immunology.
[8] L. Lanier,et al. Immune inhibitory receptors. , 2000, Science.
[9] N. Shastri,et al. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages , 2000, Nature Immunology.
[10] T. Mcclanahan,et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. , 2000, Immunity.
[11] A. Sette,et al. 4-1BB Costimulation Is Required for Protective Anti-Viral Immunity After Peptide Vaccination1 , 2000, The Journal of Immunology.
[12] Mamoru Ito,et al. CD27-Mediated Activation of Murine NK Cells1 , 2000, The Journal of Immunology.
[13] R. Glas,et al. Recruitment and Activation of Natural Killer (Nk) Cells in Vivo Determined by the Target Cell Phenotype , 2000, The Journal of experimental medicine.
[14] G. Sica,et al. Modulation of the immune response through 4-1BB. , 2000, Advances in experimental medicine and biology.
[15] M. Bachmann,et al. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. , 1999, Journal of immunology.
[16] A Steinle,et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.
[17] Jun Wu,et al. An activating immunoreceptor complex formed by NKG2D and DAP10. , 1999, Science.
[18] H. Warren,et al. Quantitative analysis of the effect of CD16 ligation on human NK cell proliferation. , 1999, Journal of Immunology.
[19] Lieping Chen,et al. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. , 1998, Cellular immunology.
[20] M. Smyth,et al. An Essential Role for Tumor Necrosis Factor in Natural Killer Cell–mediated Tumor Rejection in the Peritoneum , 1998, The Journal of experimental medicine.
[21] T. Mak,et al. CD28-independent, TRAF2-dependent Costimulation of Resting T Cells by 4-1BB Ligand , 1998, The Journal of experimental medicine.
[22] F. Kos. Regulation of adaptive immunity by natural killer cells , 1998, Immunologic research.
[23] Lieping Chen,et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors , 1997, Nature Medicine.
[24] C. Biron. Activation and function of natural killer cell responses during viral infections. , 1997, Current opinion in immunology.
[25] T. Mak,et al. Costimulation of CD28- T lymphocytes by 4-1BB ligand. , 1997, Journal of immunology.
[26] E. Engleman,et al. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. , 1996, Cellular immunology.
[27] T. Whiteside,et al. Divergent effects of FcγRIIIA ligands on the functional activities of human natural killer cells in vitro , 1996, European journal of immunology.
[28] E. Engleman,et al. Requirement for natural killer cells in the induction of cytotoxic T cells. , 1995, Journal of immunology.
[29] M. Harada,et al. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. , 1995, Immunology.
[30] G. Trinchieri. Natural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis. , 1995, Seminars in immunology.
[31] M. Caligiuri,et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor , 1994, The Journal of experimental medicine.
[32] W. Seaman,et al. Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules. , 1992, Journal of immunology.
[33] G. Trinchieri,et al. Biology of Natural Killer Cells , 1989, Advances in Immunology.
[34] R. Herberman,et al. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells , 1975, International journal of cancer.
[35] R. Herberman,et al. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity , 1975, International journal of cancer.
[36] R. Kiessling,et al. „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype , 1975, European journal of immunology.
[37] R. Kiessling,et al. „Natural”︁ killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell , 1975, European journal of immunology.